St. Jude Medical, Inc.  

(Public, NYSE:STJ)   Watch this stock  
Find more results for St. Jude Medical Inc
+0.68 (1.17%)
Oct 20 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 57.68 - 58.99
52 week 54.80 - 71.90
Open 58.02
Vol / Avg. 2.58M/1.87M
Mkt cap 16.59B
P/E 19.45
Div/yield 0.27/1.83
EPS 3.03
Shares 284.56M
Beta 1.35
Inst. own 86%
Oct 15, 2014
Q3 2014 St. Jude Medical Inc Earnings Release
Oct 15, 2014
Q3 2014 St. Jude Medical Inc Earnings Call
Sep 9, 2014
St. Jude Medical Inc at Morgan Stanley Healthcare Conference
Aug 7, 2014
St. Jude Medical Inc at Piper Jaffray Heartland Summit(Getting New Devices Into Hospitals)
Aug 7, 2014
St. Jude Medical Inc at Piper Jaffray Heartland Summit(Heart Failure from a Device Perspective)
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 16.91% 12.58%
Operating margin 19.68% 19.11%
EBITD margin - 23.67%
Return on average assets 9.00% 7.09%
Return on average equity 23.50% 17.37%
Employees 16,000 -
CDP Score - -


ST. PAUL, MN 55117
United States - Map
+1-651-7562000 (Phone)
+1-651-7563301 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


St. Jude Medical, Inc. (St. Jude) develops, manufactures and distributes cardiovascular medical devices. Its principal products in each therapy area are: Cardiac Rhythm Management - tachycardia implantable cardioverter defibrillator systems (ICDs) and bradycardia pacemaker systems (pacemakers); Cardiovascular - vascular products, which include vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories, and structural heart products, which include heart valve replacement and repair products and structural heart defect devices; Atrial Fibrillation - electrophysiology (EP) introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems, and Neuromodulation - neurostimulation products. In August 2014, the Company acquired privately held NeuroTherm, Inc., a manufacturer of interventional pain management therapies.

Officers and directors

Daniel J. Starks Chairman of the Board, President, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Donald J. Zurbay Chief Financial Officer, Vice President - Finance
Age: 46
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joel D. Becker President - Americas Division
Age: 46
Bio & Compensation  - Reuters
Eric S. Fain M.D. Group President - St. Jude Medical
Age: 53
Bio & Compensation  - Reuters
Denis M. Gestin President - International
Age: 50
Bio & Compensation  - Reuters
Michael T. Rousseau Chief Operating Officer
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John C. Heinmiller Executive Vice President
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark W. Murphy Vice President - Information Technology, Chief Information Officer
Age: 45
Bio & Compensation  - Reuters
Lisa M. Andrade Chief Marketing Officer, Vice President
Age: 42
Bio & Compensation  - Reuters
Scott P. Thome Vice President - Global Operations and Supply Chain
Age: 51
Bio & Compensation  - Reuters